THE INFLUENCE OF THE MAIN SOURCES OF INFORMATION ON THE DECISION OF VACCINATING/NON VACCINATING CHILDREN BETWEEN THE AGES OF 10-14 AGAINST HPV INFECTION.

Slides:



Advertisements
Similar presentations
Overview of HPV vaccination Training GardasilTM
Advertisements

CANCER SCREENING 2011 DELAWARE CANCER EDUCATION ALLIANCE STEPHEN S. GRUBBS, M.D. HELEN F. GRAHAM CANCER CENTER DELAWARE CANCER CONSORTIUM OCTOBER 5, 2011.
Introduction I would like to investigate the extent to which both young people and adults feel that young people also can and should have a say in the.
University Research Ethics Committee Workshop on procedure and data protection issues 30th May 2008.
STOP HPV, Oklahoma: HPV is not for me! University of Oklahoma School of Community Medicine Summer Institute 2011 Marie Roy, Jennifer Crone, Megan Cunningham,
1 THE POSSIBLE INFLUENCE OF THE MEDICAL STAFF INVOLVED IN THE ORGANIZED CERVICAL CANCER (CC) SCREENING OVER THE RESPONSIVENESS TO THE CENTRALLY ISSUED.
You are the Key to HPV Cancer Prevention Understanding the Burden of HPV Disease, the Importance of the HPV Vaccine Recommendation, and Communicating about.
ANNE MURUGI1,2 1.Amref Health Africa 2.University of Nairobi
What is HPV? Estimated to be the most common sexually transmitted infection in the United States.
Sydney Z. Spiesel, PhD MD Yale University School of Medicine.
By: Jennifer Cox.  HPV is the most common sexually transmitted disease affecting more than 20 million people in the U.S.  HPV is responsible for 70%
Human Papillomavirus (HPV)
Educational Module Cervical Cancer Screening.  Estimated new cases: 610  Estimated deaths: 150 Regular Pap tests combined with the HPV vaccine can.
HPV and Cervical Cancer Screening and Prevention.
Social marketing study Questionnaire. One of the activities planned in the Comenius Multilateral Project "We promote our region and country-Europe Young.
Mandatory Childhood/Adolescent Immunizations (HPV) Elizabeth Junemann Sarah knoll.
HPV & Cervical Cancer Frequently Asked Questions HPV & Cervical Cancer Prevention 2009 International Toolkit.
The Facts About Gardasil By Andrew Coldrick. The advert 9Fbishttp:// 9Fbis.
Women’s First Health Center Drs. Sylvester, Youngren, Lo and Sansobrino What You Should Know About Cervical Cancer: Part one in a series of four updates.
What Is HPV? Human Papillomaviruses have an icosahedral shape, contain DNA, and are non-enveloped There are at least 100 different types of HPV Over 30.
Gardasil Nicole Kettner, Guy Hamilton, Nathalie Besse.
Facts and Prevention Presented By: Ashley Austin-Yearwood, John Cyril Quarshie, Lauren Decker, Jamison Halliwell.
Reporting women’s attitudes to preventive gynaecological healthcare: survey of more than 6000 women in three European countries EUROGIN February.
 Your family, friends, teachers and the media affect the way you see yourself.  Gender is directly linked to your identity.
HPV An oncologists perspective. What is an adult oncologist doing here?
AVVAIS, RBC/IHDPC, RRP +, UNAIDS SAHARA CONFERENCE Port-Elisabeth, South Africa HIV Stigma Index 2009 Rwanda November 28 to December 2, 2011.
The HPV Vaccine: Protecting Your Daughter from Cervical Cancer Your questions deserve trusted answers.
Human Papilloma Virus Amy Baker.
The Facts About Gardasil By Andrew Coldrick. The advert.
The Second Cancer Vaccine: Human Papillomavirus Vaccine Meg Fisher, MD Medical Director.
Source: projectaccept.org. Did you know… HPV is the most common sexually transmitted infection in the U.S. Nearly all sexually active people will get.
Strategies for improving immunisation rates. Factors associated with low vaccine uptake –parents Socio-demographic variables – Certain groups of people,
Find more at Teaching ScienceTeaching Science This work is licensed under a Creative Commons Attribution- NonCommercial-ShareAlike 3.0 Unported License.Creative.
GARDASIL Vaccination HEALTH PROMOTION PROJECT BRANDI MALSY DECEMBER 3, 2014.
Position on HPV vaccinesAvailable from In July 2013, The Global Advisory Committee on Vaccine Safety (GACVS) of the WHO reconfirmed that there had been.
Responding to Vaccine Hesitant Parents Krista Rietberg, MPH Lauren Greenfield BSN, RN David Bibus, MPH Jeffrey Duchin, MD Public Health - Seattle & King.
CERVICAL CANCER: A PUBLIC HEALTH ISSUE IN ROMANIA Cornelia Rada Romanian Academy, Institute of Anthropology, Bucharest Ileana Prejbeanu University of Medicine.
WIAAP HPV Quality Improvement Project Spring 2016 Update Sarah Campbell, M.D. Mala Mathur, M.D., M.P.H.
Cynthia Bonilla HPV for Dummies D’Nae Smith Armoni Mcafee.
Dacy Gaston NSG  According to the CDC (2014)  “Human papillomavirus (pap-ah-LO-mah-VYE-rus) (HPV) is the most common sexually transmitted virus.
The Head Start Program Health Screenings By: Lillian Henderson.
Knowledge Base of Female College Students Regarding Human Papillomavirus (HPV) and Vaccination Lynn Takeshita Chloe Nobuhara Earl Hishinuma, Ph.D. Junji.
Strategies for Monitoring the Impact of HPV Vaccination Using Population-Based Data Rain Mocello, MPH California DPH STD Control Branch.
“Take the Test: Not the Risk” HPV and Cervical Cancer Cervical Cancer is Preventable!
Chapter 29 Human Papilloma Virus Infection and Immunity.
#AIDS2016 Cervical Cancer Prevention in Africa: The Future Nelly Yatich, DrPH University of California San Francisco July 19 th, 2016.
Demographics of Parents
Vaccinating at AGE SHOW ME THE EVIDENCE Debbie Saslow, PhD
Human Papillomavirus (HPV)
SWİNE FLU AWARENESS OF PHYSİCİANS
You are the Key to HPV Cancer Prevention
A Quality improvement initiative
School of Life and Health Sciences, University of Ulster Jordanstown
HPV VACCINES Dr. Kirtan Krishna.
Maya B. Mathur Castilleja School, Palo Alto, CA
Module 6 Communicating about HPV Vaccine with Stakeholders CervarixTM
10 Things You Should Know About HPV
Module 6 Communicating about HPV Vaccine with Stakeholders CervarixTM
Module 6 Communicating about HPV Vaccine with Stakeholders GardasilTM
Module 6 Communicating about HPV Vaccine with Stakeholders CervarixTM
Patient Autonomy & Informed consent
10 Things You Should Know About HPV
Module 6 Communicating about HPV Vaccine with Stakeholders GardasilTM
Knowledge, Attitudes, and Practices Regarding Cervical Cancer and Screening Dr Ghufran Jassim MBBS,MD, MSc, PhD 8/30/2017.
Module 6 Communicating about HPV Vaccine with Stakeholders GardasilTM
Serik Tursunaliev, Veronica Ross
Provider comparison reveals no difference between training levels
Megan Masters, MSN Candidate DePaul University School of Nursing
SEXUALLY TRANSMITTED INFECTIONS (STIs) PREVENTION & CARE
Presentation transcript:

THE INFLUENCE OF THE MAIN SOURCES OF INFORMATION ON THE DECISION OF VACCINATING/NON VACCINATING CHILDREN BETWEEN THE AGES OF AGAINST HPV INFECTION FIRST AUTHOR: ADELINA SOFIA GRIGORE CO-AUTHORS: ANDRIES ADRIANA, RALUCA ADELA CRACIUN COORDINATOR: LECTURER SEPTIMIU VOIDĂZAN

Romania holds the first place in Europe in terms of mortality due to cervical cancer. Every year more than 4000 new cases are reported in Romania, placing the cervical cancer on the third place in occurrence, after breast cancer and colorectal cancer. With a total of diagnosed patients, our country holds the first place in Europe in terms of mortality owed to cervical cancer, that is 6.3 times more than in the other European countries. The HPV infection is correlated in 99,7% of the cases with cervical cancer, and it is considered as an etiological factor in the cervical cancer development

The HPV infection is the most common STD in the world. There are more than 100 different types of HPV from which 15 of them determine cancerous lesions, type 16 and 18 being responsible for 70% of all cervical cancers and some in men (anal and oropharyngeal cancer) Usually the HPV infection is transitory, disappearing in a couple of months, without any signs or symptoms. Although, if the infection persists long enough, the high risk types of HPV will determine precancerous lesions and finally cervical cancer In the year 2006/2007 two vaccines were licensed (Gardasil and Cervarix) against HPV oncogenic type 16 and 18 and type 11 and 6 Anti HPV vaccination offers the best protection for boys and girls who are vaccinated properly and have the necessary time to develop their immune response before becoming sexual active. This is why the guidelines suggestions are that the vaccination should be provided around the age of 11 years In 2008 in Romania there was a National Vaccination campaign against HPV type 16 and 18 and it was addressed to school girls between the ages of The campaign was unsuccessful, many parents refusing the vaccination.

Objective The purpose of the study was to find a correlation between the HPV infection/vaccine information source and the decision whether to vaccinate or not.

- We applied a cross-sectional study using questionnaires which were given to parents of children from 3 random schools from Târgu Mureș - At the beginning of the questionnaire we mentioned the purpose of the study, the guarantee of anonymity and confidentiality of the provided data. For the Hungarian speaking parents we administrated questionnaires translated in Hungarian. Our study was approved by the Ethics Committee of the University of Medicine and Pharmacy Tg Mures. Materials and Methods

The questionnaire was composed of 34 questions divided into 9 categories, such as: demographics data/ educational level of the parent/ knowledge about HPV infection/ the quality of information received from the family physician about cervical cancer/ level of knowledge regarding the vaccine/ reasons for non- vaccinating/ awareness that their daughter could get infected with HPV/ the intention to vaccinate their daughter in the future and the parent’s point of view regarding the best ways to get informed in the next vaccination campaigns

3 schools from Targu Mures were chosen randomly. The teachers gave the children a sealed envelope. The questionnaires were answered in a time frame of 2 weeks by the parents and brought back to school to be collected. The data collection took part between. From 1100 administered questionnaires,918 parents agreed to participate in the study, that means a response rate of 83.4%

The average age of the parents was that of 40 years old, with a minimum of 28 years and a maximum of 57 years old.

Based on their current level of awareness, 1 out of 3 parents would vaccinate their child against HPV. The main reasons for non-vaccination were: fear of the side effects, the vaccine is a new one and it’s not sufficiently studied, or that they are not informed about this vaccine.

Results 42% of the parents who were informed by the family physician want to vaccinate their child. From the parents who asked their family doctor for information, 44,2% would want to vaccinate. Other information sources (friends, family, specialty books, mass media and the internet) do not impact the vaccination decision. The quality of the information given by the media was doubtful, it does not increase the level or quality of knowledge and it can influence the decision of vaccination

Results The family doctor’s role, through his correct information, is considered to have an important part in determining the parent to vaccinate his child. The decision is strongly influenced if the parent received information about prevention methods of HPV, vaccine recommendations, vaccine benefits. Even more, beside these information provided by the family doctor, the knowledge about complete protection, precaution from other persons or family history of cancer, improve considerably (68.8%) the parent attitude towards vaccination.

Conclusions The parents who received information from the family doctor were the ones who, on a scale from 1(very low) to 5(excellent) graded their knowledge of HPV infection/vaccination 4 or 5, proving that the information given by the doctors are the most relevant. Educational campaigns would have a higher success if they were to be performed by the family/school doctor. The physician would have to give explanations regarding the prevention methods, vaccinations, screening, risk and benefits.